尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Ashar Bhavesh, Directeur Commercial. Insider active across 2 companies, notably SpringWorks Therapeutics, Inc.. Aggregated, 13 filings have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €103k. Activity tracked since 1 April 2022. The latest transaction was disclosed on 20 February 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
Ashar Bhavesh is Directeur Commercial and Chief Commercial Officer at SpringWorks Therapeutics, Inc. He has 13 filings in total, and across the sampled recent filings from 2022-01-10 to 2025-07-02, sales total 103465 EUR, with tax withholding as the most frequent transaction nature.